Management of Traditional Cardiovascular Diseases in Hemodialysis Patients: Where is the Evidence?


Date: Mar 6, 2020 01:30 PM - 02:30 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Mar 20, 2020 02:30 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacists
Pharmacy Students

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

CPE Monitor: Requirement to Track your CPE
Important new requirement from the Accreditation Council for Pharmacy Education and the National Association of Boards of Pharmacy for all pharmacists and technicians who obtain CPE credit. The CPE Monitor system will securely track all your completed CPE credits in a central system.

https://store.nabp.net/OA_HTML/xxnabpibeGblLogin.jsp 

 

Registration closes on Mar 20, 2020 at 02:30 PM

Registration Closed  

Objectives

  • Discuss traditional CV risk factors in CKD patients
  • Summarize the current clinical guidelines for modification hyperlipidemia and CHF in hemodialysis patients
  • Summarize the existing evidence for modification hyperlipidemia and CHF in hemodialysis patients
  • Identify knowledge gaps in the current evidence
  • Summarize approaches to bridge the knowledge gap in treatment of hyperlipidemia and CHF in hemodialysis patients

Speaker(s)/Author(s)

Chiemena Ohanele

Activity Number

0010-0000-20-002-L01-P
Date: 03/06/20
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
Registration Closed